|
|||||
|
|
A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteers |
|
| Authors: | D. Shin MD PhD Y. Lee PhD H. Kim PhD T. Körnicke MD R. Fuhr MD PhD |
| Affiliation: | 1. Samsung Bioepis Co., Ltd, Incheon, Korea;2. PAREXEL International GmbH, Berlin, Germany |
| Abstract: | |
| Keywords: | bioequivalence biosimilar clinical pharmacokinetics |